Cargando…
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment
Bortezomib, a novel proteasome inhibitor, has been approved for treating multiple myeloma and mantle cell lymphoma and studied pre-clinically and clinically for solid tumors. Preferential cytotoxicity of bortezomib was found toward hypoxic tumor cells and endothelial cells in vitro. The purpose of t...
Autores principales: | Sun, Xiaorong, Ackerstaff, Ellen, He, Fuqiu, Xing, Ligang, Hsiao, Hung Tsung, Koutcher, Jason A., Ling, C. Clifton, Li, Gloria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741486/ https://www.ncbi.nlm.nih.gov/pubmed/26416246 |
Ejemplares similares
-
A triple suicide gene strategy that improves therapeutic effects and incorporates multi-modality molecular imaging for monitoring gene-functions
por: Xing, Ligang, et al.
Publicado: (2013) -
Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cells
por: HSIAO, HUNG TSUNG, et al.
Publicado: (2014) -
Corrigendum to “Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia” [Neoplasia 11 (2009) 247-259]
por: Cho, HyungJoon, et al.
Publicado: (2016) -
Metabolic Plasticity of Metastatic Breast Cancer Cells: Adaptation to Changes in the Microenvironment()
por: Simões, Rui V., et al.
Publicado: (2015) -
Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)